Stauber Performance Ingredients in Fullerton sold for $157 million to Hawkins Inc. in Roseville, Minn.
Middle-market investor ICV Partners in New York had owned Stauber since 2011.
Stauber makes ingredients for food, pharmaceutical, cosmetic, and pet care companies.
Hawkins is a chemicals maker with a market value of about $380 million that plans to expand its product line with a buy.
Stauber has annual revenue of $117 million and 160 employees here and in New York.
Hawkins now has 630 employees and $500 million in revenue.
ICV bought Stauber in 2011 from New Canaan, Conn. private equity owner J.H. Whitney & Co. The price wasn’t disclosed, but ICV borrowed $28 million from New York City-based Prospect Capital Corp. to fund its purchase.
ICV had about $440 million in capital under management at the time, and it held stakes in 19 companies.
It brought Stauber’s manufacturing in-house with the May 2012 purchase of Florida, N.Y.-based Pharmline Inc.
Stauber was founded in 1969 by the father of current Chief Executive Dan Stauber.
—Paul Hughes
